Therefore, pharmacologically-safe antitumor agents with potential to influence the tumor microenvironment and inhibit NF-κB signaling activation may enhance chemo-sensitivity and reduce metastasis of tumor cells, thus providing a promising approach for the prevention or treatment of tumors. This evidence concerns the gene NFKB1 and neoplasm.